Researchers use optogenetic tool to control, visualize receptor signals in neural cells

Using a novel optogenetic tool, researchers have successfully controlled, reproduced and visualized serotonin receptor signals in neural cells. To this end, they modified a photosensitive membrane receptor in the eye, namely melanopsin. As a result, they were able to switch the receptor on and off using light; it also acted like a sensor indicating via fluorescence if specific signaling pathways in the cell had been activated. The sensor was, moreover, specifically designed to migrate to those domains in the neural cells that are sensitive to the neurotransmitter serotonin. The team from Ruhr-Universität Bochum, headed by Dennis Eickelbeck and Professor Stefan Herlitze, described its project in the journal Nature Communications Biology on 14 February 2019.

Activating signaling pathways with light

Melanospin is a G-protein-coupled receptor capable of controlling specific signaling pathways in the cells. In earlier studies, the team at the Department of General Zoology and Neurobiology in Bochum had deployed the receptor as an optogenetic tool. Having modified the receptor, the biologists were able to switch it on with blue light and off with yellow light. Thus, they could activate various G-protein-coupled signaling pathways in neural cells using light.

In their current study, the researchers optimized the tool and turned it into a sensor that indicates if a G-protein-coupled signaling pathway has been switched on. The trick: once such a signaling pathway is activated, the concentration of calcium ions in the cell increases. The researchers melded melanopsin with a calcium indicator protein, whose fluorescence intensity increases following an increase in calcium concentration in the cell. Green light thus indicated that a G-protein-coupled signaling pathway had been activated.

Dual color code

Subsequently, the biologists added two more functions to their sensor, i.e. the calcium-melanopsin-local-sensor, Camello for short. They integrated a second fluorescent protein that permanently emits red fluorescence. Monitoring the red light, they were able to pinpoint the sensor in the cells, regardless if a signaling pathway was switched on or not. A red light thus indicated that the Camello sensor was present, whereas an additional green light showed that it had activated signaling pathways.

Receptor trafficking in specific domains

Finally, the researchers added a fragment of a serotonin receptor to Camello. As a result, the sensor was trafficked to those domains of the cell where serotonin receptors occur naturally. "Since serotonin is involved in numerous processes in the central nervous system, it also plays an important role in many disorders, such as depression, schizophrenia, anxiety and migraine. We are hoping that, by facilitating detailed research into the transport, localization and activity of relevant receptors, our tool will help us understand the mechanisms underlying these diseases," says Dennis Eickelbeck.​

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Tirzepatide significantly reduces weight and diabetes risk in patients with obesity and prediabetes